Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    " January 11, 2008":" February 08, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
Condition: HIV Infections
Intervention: Drug: tipranavir/ritonavir (dose reduction)
22 Completed Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
Conditions: HIV Infections;   Substance Use
Intervention: Behavioral: Safer Sex Skills Building (SSB)
23 Unknown  Stress-Reducing Interventions in HIV+ Patients: Pilot
Conditions: Stress Disorders, Post-Traumatic;   HIV Infections
Intervention: Behavioral: Prolonged Exposure Therapy
24 Terminated Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Condition: HIV Infections
Interventions: Drug: apricitabine;   Drug: lamivudine
25 Terminated
Has Results
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir; valproic acid
26 Unknown  Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Lumefantrine-artemether and nevirapine;   Drug: lumefantrine-artemether and efavirenz;   Drug: Lumefantrine-artemether and rifampicin
27 Completed
Has Results
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
Conditions: HIV Infections;   Sexually Transmitted Diseases
Intervention: Biological: Quadrivalent HPV vaccine
28 Completed
Has Results
TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy
Conditions: Lipodystrophy;   HIV Infections
Interventions: Drug: Tesamorelin;   Drug: Placebo for Tesamorelin
29 Completed Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Nevirapine without dose escalation;   Drug: Nevirapine initiation with dose escalation
30 Unknown  Efficacy of Group Intervention to Reduce Stress Symptoms
Conditions: Stress Disorders, Post-Traumatic;   HIV Infections
Intervention: Behavioral: HIV Skills-based Prevention
31 Completed Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4
Conditions: HIV Infections;   Hepatitis C
Intervention: Drug: Peginterferon alfa-2a + ribavirin
32 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with efavirenz;   Drug: rifabutin in combination with nevirapine;   Drug: rifabutin in combination with lopinavir/ritonavir
33 Completed HIV and Hepatitis Care Coordination in Methadone Treatment
Conditions: Hepatitis, Viral, Human;   HIV Infections
Interventions: Behavioral: Testing, Education, & Counseling (TEC);   Behavioral: Hepatitis Care Coordination (HCC)
34 Completed An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV
Condition: HIV
Interventions: Behavioral: Counseling sessions;   Behavioral: Group workshop
35 Terminated Effect of Omacor on Triglycerides in HIV Infected Subjects
Condition: Hyper-Triglyceridemia
Interventions: Drug: Omacor;   Drug: Placebo
36 Unknown  Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV
Conditions: Chronic Hepatitis C;   Co-Infection HIV-HCV
Intervention: Drug: Peg interferon + Ribavirin
37 Unknown  Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction
Conditions: Heroin Dependence;   Opiate Dependence;   Substance Dependence
Interventions: Behavioral: CRAFT-T;   Behavioral: Treatment as usual

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Study has passed its completion date and status has not been verified in more than two years.